Skip to primary navigation
Skip to main content
Skip to footer

Neurotech International

ASX:NTI

Home
Corporate
Development Programs
Investors
Contact

Neurotech inks European development deal for cannabinoid therapies

13 February 2025 News & Media

Read the full article here.

Footer

Suite 102 / Level 1, 55 Collins Street
Melbourne VIC 3000
Australia

moc.l1780572862anoit1780572862anret1780572862nihce1780572862torue1780572862n@ofn1780572862i1780572862

+61 (3) 9498 3132

Subscribe to our latest announcements

"*" indicates required fields

Name*

First Last

Email*

Email

This field is for validation purposes and should be left unchanged.

Copyright © 2026 Neurotech International • Site by White Noise Communications

Download prospectus